00205 BFB HEALTH
按盘价 
0.680 0.000 (0.000%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | -1.530% | -9.855% | -5.775% | -17.940% | -8.067% |
| 股东资金回报率 (%) | -2.884% | -18.091% | -10.961% | -34.392% | -14.965% |
| 资本运用回报率 (%) | -2.316% | -19.108% | -11.532% | -36.129% | -15.238% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 49.017% | 41.179% | 29.263% | 56.371% | 60.950% |
| 未计利息、税项、折旧及摊销前利润率 (%) | -56.862% | -10.570% | -86.521% | -112.703% | -41.416% |
| 税前边际利润率 (%) | -59.087% | -97.519% | -105.435% | -119.314% | -63.697% |
| 纯利率 (%) | -16.729% | -114.742% | -60.656% | -112.725% | -58.721% |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 2.112 X | 2.189 X | 2.003 X | 1.983 X | 2.021 X |
| 速动比率 (X) | 2.089 X | 2.189 X | 2.003 X | 1.983 X | 2.021 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 44.503% | 51.901% | 52.119% | 51.873% | 47.847% |
| 总债项 / 总资产比率 (%) | 6.985% | 12.334% | 8.939% | 9.412% | 2.828% |
| 净债项 / 总资产比率 (%) | 0.254% | 6.285% | -1.888% | -10.016% | -2.272% |
| 总债项 / 股东资金比率 (%) | 13.414% | 22.749% | 16.343% | 18.487% | 5.310% |
| 长期债项 / 股东资金比率 (%) | 6.940% | 14.633% | 9.852% | 10.425% | 2.552% |
| 净债项 / 股东资金比率 (%) | 0.488% | 11.591% | -3.451% | -19.672% | -4.266% |
| 净现金 / (债项) ($) | (1.02百万) | (2.03千万) | 7.15百万 | 4.28千万 | 1.12千万 |
| 每股净现金 / (债项) ($) | (0.001) | (0.024) | 0.009 | 0.058 | 0.018 |
| 总债项 / 资本运用比率 (%) | 11.716% | 22.012% | 16.780% | 17.614% | 5.284% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 79.490日 | N/A | N/A | N/A | N/A |
| 应收贸易帐周转率日数 (日) | 475.794日 | 654.690日 | 600.283日 | 474.119日 | 699.225日 |
| 应付贸易帐周转率日数 (日) | 202.631日 | 206.270日 | 164.116日 | 140.826日 | 212.619日 |
| 备注： | 实时报价更新时间为02/04/2026 16:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | HKD -5,540 |
| 增长率 | -83.987% |
| 每股盈利/(亏损) | HKD -0.006 |
| 每股账面资产净值 ($) | HKD 0.167 |